Searched for
ADITYA KHEMKA STOCKS
Pharma calls in sick after Trump’s 100% tariff threatPharma stocks fell Thursday after reports of US President Donald Trump mulling 100% tariffs on imported branded and patented medicine maker...
Aditya Khemka on US tariff threat over pharma and what to bet on thereInCred Asset Management is cautious about US-facing generic pharma companies due to potential tariff risks and single-digit earnings growth...
Hospital stocks gain on safe-haven buyingIn past one month, most hospital stocks such as Max Healthcare, Apollo Hospitals, Fortis Healthcare, Healthcare Global and Rainbow Children...
US foreign aid ban hits HIV-related local drug stocksLaurus Labs slumped 11.6%, Aurobindo declined 2%, Cipla fell 1.1% and Strides dropped 5%. Other pharma shares also declined with 19 out of ...
How will Biosecure Act impact Indian pharma companies? Aditya Khemka explainsWe own a stock here called Jubilant Pharmova. The company was given a grant from the US government to create a manufacturing facility on th...
‘Defensive’ pharma scales new peak as Street looks beyond high-growth playsPharma stocks have gained investor interest as the Nifty Pharma index reaches new highs. Amid economic uncertainties, defensive sectors lik...
ETMarkets Smart Talk: There will be political stability; healthcare could turn out to be the dark horse in FY25: Aditya KhemkaGlobal investors haven't got much choice but to remain invested in India and perhaps increase allocations despite the political uncertainty.
Rs 31,09,459 crore m-cap loss! Correction the start of a stock picker’s marketLower-than-expected BJP seats erase Nifty gains. Nifty falls by 5.93%, still trades expensively. India and Japan rally on economic growth a...
Trend of larger, more liquid hospital stocks getting more exorbitantly priced to continue: Aditya KhemkaAditya Khemka of InCred Healthcare PMS discusses the overvaluation of hospital stocks due to liquidity chasing the asset. Liquidity is driv...
Why Aditya Khemka avoids largecap pharma, prefers small & midcap stocks“Hospitals are a wonderful business. In fact, I do not think many people in the investing Street understand that barring FMCG, the only oth...
For next 2-3-years, big alpha can be generated in branded generics and diagnostics: Aditya Khemka“We generally like businesses that generate cash and we have seen lack of cash generation from Western Europe and US businesses. Yes they c...
SGX Nifty down 20 points; here's what changed for market while you were sleeping"The lower levels of India's VIX reflect market stability, instilling investor confidence and promoting long-term investments," Vinod Nair,...
US generic business won't show any significant growth for pharma companies for next 1-2 years: Aditya KhemkaOn one hand, you have the US generic business where the raw material cost decline will obviously help the margins. But you would also have ...
FY24 should see improvement in margins for pharma sector: Aditya KhemkaHowever, in FY24 what we believe is that the government will again allow pharma companies to take price increases anywhere in the range of ...
Time to invest in pharma funds for a contrarian play?Mutual Funds that bet on pharma stocks have fallen 14.2% on an average in the past one year. So far in 2022, they have declined 12.4% on an...
Siddhartha Khemka on 3 stocks to bet on now“In the passenger vehicle segment, Maruti is holding the fort as of now and has so far reported decent volume growth. That could be the onl...
Stocks that are likely to bounce on the lifting of Covid curbsAviation, hotels, multiplexes, city gas and liquor stocks could be the biggest gainers
Pick pharma stocks that have strong domestic businesses: Aditya KhemkaThere is a lot of room to improve pharma companies’ RoEs, says Fund Manager of DSP Healthcare Fund.
As market hits record high, Bajaj grows wealth fastest; Ambanis, Tatas, Adanis followThe Bajaj group are top wealth creators, with a 33.4% jump in combined market value this year. Six Adani group stocks saw a 19.27 per cent ...
DSP Mutual Fund launches DSP Healthcare FundThe NFO opens today and will close on November 26.